Clinical Implementation of a Commercial Synthetic Computed Tomography Solution for Radiotherapy Treatment of Glioblastoma

Overview

Journal Phys Imaging Radiat Oncol

Specialty Oncology

Date 2024 May 31

PMID 38818305

Authors

Sevgi Emin

Elia Rossi

Elisabeth Myrvold Rooth

Torsten Dorniok

Mattias Hedman

Giovanna Gagliardi

Fernanda Villegas

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Magnetic resonance (MR)-only radiotherapy (RT) workflow eliminates uncertainties due to computed tomography (CT)-MR image registration, by using synthetic CT (sCT) images generated from MR. This study describes the clinical implementation process, from retrospective commissioning to prospective validation stage of a commercial artificial intelligence (AI)-based sCT product. Evaluation of the dosimetric performance of the sCT is presented, with emphasis on the impact of voxel size differences between image modalities.

Materials And Methods: sCT performance was assessed in glioblastoma RT planning. Dose differences for 30 patients in both commissioning and validation cohorts were calculated at various dose-volume-histogram (DVH) points for target and organs-at-risk (OAR). A gamma analysis was conducted on regridded image plans. Quality assurance (QA) guidelines were established based on commissioning phase results.

Results: Mean dose difference to target structures was found to be within ± 0.7 % regardless of image resolution and cohort. OARs' mean dose differences were within ± 1.3 % for plans calculated on regridded images for both cohorts, while differences were higher for plans with original voxel size, reaching up to -4.2 % for chiasma D2% in the commissioning cohort. Gamma passing rates for the brain structure using the criteria 1 %/1mm, 2 %/2mm and 3 %/3mm were 93.6 %/99.8 %/100 % and 96.6 %/99.9 %/100 % for commissioning and validation cohorts, respectively.

Conclusions: Dosimetric outcomes in both commissioning and validation stages confirmed sCT's equivalence to CT. The large patient cohort in this study aided in establishing a robust QA program for the MR-only workflow, now applied in glioblastoma RT at our center.

Citing Articles

Synthetic Computed Tomography generation using deep-learning for female pelvic radiotherapy planning.

Tulip R, Andersson S, Chuter R, Manolopoulos S Phys Imaging Radiat Oncol. 2025; 33:100719.

PMID: 40008279 PMC: 11851199. DOI: 10.1016/j.phro.2025.100719.

Brain MR-only workflow in clinical practice: A comparison among generators for quality assurance and patient positioning.

Levardon M, Autret D, Le Dorze T, Guillerminet C, Dufreneix S J Appl Clin Med Phys. 2024; 26(2):e14583.

PMID: 39585187 PMC: 11799901. DOI: 10.1002/acm2.14583.

Results of 2023 survey on the use of synthetic computed tomography for magnetic resonance Imaging-only radiotherapy: Current status and future steps.

Fusella M, Alvarez Andres E, Villegas F, Milan L, Janssen T, Dal Bello R Phys Imaging Radiat Oncol. 2024; 32:100652.

PMID: 39381612 PMC: 11460247. DOI: 10.1016/j.phro.2024.100652.

References

Metcalfe P, Liney G, Holloway L, Walker A, Barton M, Delaney G . The potential for an enhanced role for MRI in radiation-therapy treatment planning. Technol Cancer Res Treat. 2013; 12(5):429-46. PMC: 4527434. DOI: 10.7785/tcrt.2012.500342. View

Chandarana H, Wang H, Tijssen R, Das I . Emerging role of MRI in radiation therapy. J Magn Reson Imaging. 2018; 48(6):1468-1478. PMC: 6986460. DOI: 10.1002/jmri.26271. View

Neppl S, Landry G, Kurz C, Hansen D, Hoyle B, Stocklein S . Evaluation of proton and photon dose distributions recalculated on 2D and 3D Unet-generated pseudoCTs from T1-weighted MR head scans. Acta Oncol. 2019; 58(10):1429-1434. DOI: 10.1080/0284186X.2019.1630754. View

Ranta I, Wright P, Suilamo S, Kemppainen R, Schubert G, Kapanen M . Clinical feasibility of a commercially available MRI-only method for radiotherapy treatment planning of the brain. J Appl Clin Med Phys. 2023; 24(9):e14044. PMC: 10476982. DOI: 10.1002/acm2.14044. View

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J, Pujol S . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012; 30(9):1323-41. PMC: 3466397. DOI: 10.1016/j.mri.2012.05.001. View

Kazemifar S, McGuire S, Timmerman R, Wardak Z, Nguyen D, Park Y . MRI-only brain radiotherapy: Assessing the dosimetric accuracy of synthetic CT images generated using a deep learning approach. Radiother Oncol. 2019; 136:56-63. DOI: 10.1016/j.radonc.2019.03.026. View

Jonsson J, Nyholm T, Soderkvist K . The rationale for MR-only treatment planning for external radiotherapy. Clin Transl Radiat Oncol. 2019; 18:60-65. PMC: 6630106. DOI: 10.1016/j.ctro.2019.03.005. View

Spadea M, Maspero M, Zaffino P, Seco J . Deep learning based synthetic-CT generation in radiotherapy and PET: A review. Med Phys. 2021; 48(11):6537-6566. DOI: 10.1002/mp.15150. View

Walker A, Liney G, Metcalfe P, Holloway L . MRI distortion: considerations for MRI based radiotherapy treatment planning. Australas Phys Eng Sci Med. 2014; 37(1):103-13. DOI: 10.1007/s13246-014-0252-2. View

10.

Ranta I, Kemppainen R, Keyrilainen J, Suilamo S, Heikkinen S, Kapanen M . Quality assurance measurements of geometric accuracy for magnetic resonance imaging-based radiotherapy treatment planning. Phys Med. 2019; 62:47-52. DOI: 10.1016/j.ejmp.2019.04.022. View

11.

Lerner M, Medin J, Gustafsson C, Alkner S, Siversson C, Olsson L . Clinical validation of a commercially available deep learning software for synthetic CT generation for brain. Radiat Oncol. 2021; 16(1):66. PMC: 8025544. DOI: 10.1186/s13014-021-01794-6. View

12.

Das I, McGee K, Tyagi N, Wang H . Role and future of MRI in radiation oncology. Br J Radiol. 2018; 92(1094):20180505. PMC: 6404845. DOI: 10.1259/bjr.20180505. View

13.

Dinkla A, Wolterink J, Maspero M, Savenije M, Verhoeff J, Seravalli E . MR-Only Brain Radiation Therapy: Dosimetric Evaluation of Synthetic CTs Generated by a Dilated Convolutional Neural Network. Int J Radiat Oncol Biol Phys. 2018; 102(4):801-812. DOI: 10.1016/j.ijrobp.2018.05.058. View

14.

Wang T, Lei Y, Fu Y, Wynne J, Curran W, Liu T . A review on medical imaging synthesis using deep learning and its clinical applications. J Appl Clin Med Phys. 2020; 22(1):11-36. PMC: 7856512. DOI: 10.1002/acm2.13121. View

15.

Boulanger M, Nunes J, Chourak H, Largent A, Tahri S, Acosta O . Deep learning methods to generate synthetic CT from MRI in radiotherapy: A literature review. Phys Med. 2021; 89:265-281. DOI: 10.1016/j.ejmp.2021.07.027. View

16.

Nagtegaal S, van Lier A, den Boer A, Kramer M, Fanetti G, Eppinga W . Does an immobilization mask have added value during planning magnetic resonance imaging for stereotactic radiotherapy of brain tumours?. Phys Imaging Radiat Oncol. 2021; 13:7-13. PMC: 7807597. DOI: 10.1016/j.phro.2020.02.003. View

17.

Maspero M, Bentvelzen L, Savenije M, Guerreiro F, Seravalli E, Janssens G . Deep learning-based synthetic CT generation for paediatric brain MR-only photon and proton radiotherapy. Radiother Oncol. 2020; 153:197-204. DOI: 10.1016/j.radonc.2020.09.029. View

18.

Tang B, Wu F, Fu Y, Wang X, Wang P, Orlandini L . Dosimetric evaluation of synthetic CT image generated using a neural network for MR-only brain radiotherapy. J Appl Clin Med Phys. 2021; 22(3):55-62. PMC: 7984468. DOI: 10.1002/acm2.13176. View

19.

Liu F, Yadav P, Baschnagel A, McMillan A . MR-based treatment planning in radiation therapy using a deep learning approach. J Appl Clin Med Phys. 2019; 20(3):105-114. PMC: 6414148. DOI: 10.1002/acm2.12554. View

20.

Bourbonne V, Jaouen V, Hognon C, Boussion N, Lucia F, Pradier O . Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain Radiotherapy. Cancers (Basel). 2021; 13(5). PMC: 7959466. DOI: 10.3390/cancers13051082. View